G1 Therapeutics, Inc.
News
Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period
Globe Newswire HOLBAEK, Denmark and RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Pharmacosmos A/S, a leader in the development of innovative treatments for patients suffering from iron...\n more…
G1 Therapeutics, Inc. (NASDAQ:GTHX) Shares Acquired by SG Americas Securities LLC
Ticker Report SG Americas Securities LLC increased its position in shares of G1 Therapeutics, Inc. (NASDAQ:GTHX - Free Report) by 248.1% during the second quarter, according to its most recent Form 13F filing with...\n more…
Wedbush Brokers Boost Earnings Estimates for G1 Therapeutics, Inc. (NASDAQ:GTHX)
Ticker Report G1 Therapeutics, Inc. (NASDAQ:GTHX - Free Report) - Research analysts at Wedbush upped their Q3 2024 earnings per share estimates for G1 Therapeutics in a report released on Thursday, August 8th...\n more…
G1 Therapeutics (NASDAQ:GTHX) Posts Earnings Results, Beats Expectations By $0.07 EPS
Ticker Report G1 Therapeutics (NASDAQ:GTHX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.10) EPS for the quarter, topping analysts' consensus estimates of ($0.17) by $0.07...\n more…
